Yu Minzhi, Vaishnav Saatvik, Dorsey Kristen Hong, Phoo May Thazin, Rodriguez Antonela, Schwendeman Anna
Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Nanomedicine. 2025 Jan;63:102795. doi: 10.1016/j.nano.2024.102795. Epub 2024 Nov 16.
Apolipoprotein-based, synthetic high-density lipoprotein (sHDL) nanodiscs have been extensively studied as a potential therapeutic agent for cardiovascular disease due to their ability to promote reverse cholesterol transport. Recently, polymer-based nanodiscs have been made possible with the development of novel polymeric materials such as styrene-maleic anhydride copolymer (SMA). While the polymer-based nanodiscs resemble the discoidal structure of sHDLs, their functional similarity with sHDL has not been investigated. In the present study, we compared the SMA-based and peptide-based sHDL nanodiscs focusing on their cholesterol mobilization effects. Results showed that SMA-based nanoparticles presented similar particle size and in vitro cholesterol efflux effect to those of sHDL nanodiscs. However, SMA nanodiscs induced less cholesterol mobilization in vivo, possibly due to insufficient cholesterol esterification by lecithin:cholesterol acyltransferase.
基于载脂蛋白的合成高密度脂蛋白(sHDL)纳米盘因其促进胆固醇逆向转运的能力,作为心血管疾病的潜在治疗剂已得到广泛研究。最近,随着新型聚合物材料如苯乙烯-马来酸酐共聚物(SMA)的发展,基于聚合物的纳米盘成为可能。虽然基于聚合物的纳米盘类似于sHDL的盘状结构,但它们与sHDL的功能相似性尚未得到研究。在本研究中,我们比较了基于SMA和基于肽的sHDL纳米盘,重点关注它们的胆固醇动员作用。结果表明,基于SMA的纳米颗粒呈现出与sHDL纳米盘相似的粒径和体外胆固醇流出效应。然而,SMA纳米盘在体内诱导的胆固醇动员较少,这可能是由于卵磷脂:胆固醇酰基转移酶的胆固醇酯化不足所致。